Safety and Immunogenicity Study of Recombinant Thrombin (rThrombin) in Pediatric Participants

NCT00859547 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Blood Loss, Surgical

Interventions

BIOLOGICAL: rThrombin, 1000 IU/mL

Sponsor

ZymoGenetics